Clinical Trial Update: Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated nitazoxanide in combination with peginterferon and ribavirin for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)
• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Chronic Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED